Navigation Links
Indevus Announces Submission of New Drug Application
Date:8/28/2007

y the analysis of the safety measurements collected and the persistence with study treatment. Further, the spectrum of adverse events reported were comparable to other injectable hypogonadism treatments reported in the literature. There were no significant adverse changes in laboratory parameters with NEBIDO treatment.

About NEBIDO

NEBIDO(R) is a long-acting depot preparation of testosterone undecanoate, developed for the treatment of male hypogonadism. NEBIDO is expected to be the first three-month testosterone preparation available in the U.S. in the growing market for testosterone therapies. Indevus acquired U.S. rights to NEBIDO from Bayer Schering Pharma AG, Germany in July 2005.

About Hypogonadism

Male hypogonadism is an increasingly recognized medical condition characterized by a reduced or absent secretion of testosterone from the testes. Reduced testosterone levels can lead to health problems and significantly impair quality of life. Common effects of hypogonadism include decreased sexual desire, muscle loss and weakness, as well as an increased risk of osteoporosis. Today, there are an estimated four to five million men in the U.S. who suffer from hypogonadism. Of this group, less than ten percent are currently receiving treatment with testosterone therapy.

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) XR and SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate cancer, SUPPRELIN(R) LA, for central precocious puberty, and DELATESTRYL(R) to treat male hypogonadism. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(R) for bladder c
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Indevus Announces Presentation of Pagoclone Data at 47th Annual New Clinical Drug Evaluation Unit Meeting
2. Indevus Reports Positive Data From Phase III NEBIDO Trial
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2014 Financial Results and Highlights Conference CallWhen:Monday, August 4 ... How:Live on the Internet. Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:7/28/2014)... , July 28, 2014 ... £2.5 million to help it meet the global ... healthcare, pharmaceuticals and logistics. Albion joins Shackleton Ventures. ... Over the past 18 months OmPrompt ... platform, its management team and its operations. The ...
(Date:7/25/2014)... July 25, 2014  Depomed, Inc. (NASDAQ: ... quarter fiscal year 2014 financial results after the market ... a conference call beginning at 4:30 pm EDT, 1:30 pm PDT ... the call by dialing 877-317-6789 ( United States ... also be available via a live webcast on the ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2
... Feb. 28, 2012   New Mexico Software, Inc. , d/b/a ... NMXC ), a developer of medical IT solutions and ... community, announced today that the company,s long standing suit brought ... judgment in favor of New Mexico Software. The ...
... 2012   Alexander Orthopaedic Associates (AOA) in Largo, FL, ... their practice with White Plume Technologies between Exscribe ... (ADSC) practice management system (PM system). EMRs ... the billing process unfilled. White Plume Technologies bridges ...
Cached Medicine Technology:New Mexico Software Prevails in Lawsuit 2Alexander Orthopaedic Associates Chooses White Plume Technologies to Fill the EMR Gap 2
(Date:7/28/2014)... Northridge, CA (PRWEB) July 28, 2014 ... a $100 coupon for new patients. Finding a new dentist ... anxiety or dental issues that have gone untreated and worry ... provider. Dr. Ariz specializes in patients with special concerns and ... patients feels comfortable and right at home. This special coupon ...
(Date:7/28/2014)... has released a new blog post presenting ... Comparing life insurance quotes can help clients save up ... coverage is easier online by visiting insurance brokerage websites. ... them on a single web page. , By ... but they can also learn more about life insurance. ...
(Date:7/28/2014)... Following a healthy lifestyle may help childhood cancer survivors ... study indicates. Researchers suggested that children with cancer ... about how their diet and certain behaviors ... findings are important because they indicate that adults who ... to influence their own health outcomes," said one of ...
(Date:7/28/2014)... Nevada (PRWEB) July 28, 2014 Mahendra ... Trivedi, hosted the Trivedi Online Workshop ‘Consciousness is Power’ ... PM (EST). During this workshop, participants from all over ... importance of making a deeper connection to their inner ... the participants explored the various advantages of raising consciousness ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Alta ... process outsourcing (BPO) for Fortune 500 brands, announced today ... across its locations in Wisconsin, California, Florida and the ... based at its Fort Myers campus, and the company ... The hiring is to support several health-insurance clients, which ...
Breaking Medicine News(10 mins):Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 2Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 4
... HealthDay Reporter , WEDNESDAY, Aug. 3 (HealthDay News) -- ... improve lung function in patients who haven,t been helped with ... involved in asthma, and appears to be the first drug ... Georas, a professor of medicine in the pulmonary and critical ...
... the potential to treat disorders and diseases that ... epilepsy, spinal cord injury, and Alzheimer,s and Parkinson,s. ... applications because of bodily reactions that limit device ... professor of electrical and computer engineering at Wayne ...
... ,Mountain View, CA August 3, 2011 23andMe, ... that it has launched a Myeloproliferative Neoplasms (MPN) research ... individuals with these rare blood cancers in the 23andMe ... are a group of blood and bone marrow diseases ...
... -- Vampire bats have heat-detecting molecules that help guide them ... been known that vampire bats know where to bite in ... vein, but the researchers believe this is the first study ... researchers investigated wild vampire bats in South America and discovered ...
... NY, August 3, 2011Positive activity interventions (PAIs) offer ... depression and may offer hope to individuals with ... access to adequate medical therapy, according to a ... Alternative and Complementary Medicine , a peer-reviewed journal ...
... research raises troubling concerns about the use of aggressive ... such as MRSA, C. difficile , malaria, and ... medication to kill all targeted disease pathogens has the ... are present the greatest possible evolutionary advantage," says Troy ...
Cached Medicine News:Health News:Experimental Drug Promising Against Tough-to-Treat Asthma 2Health News:Wayne State researcher receives NSF award to develop neural implants 2Health News:23andMe launches myeloproliferative neoplasms research initiative 2Health News:23andMe launches myeloproliferative neoplasms research initiative 3Health News:Harnessing the power of positive thoughts and emotions to treat depression 2
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: